Azienda USL Toscana Centro

At Azienda USL Toscana Centro in Prato, the clinical trial program is focused on neoplasms, with studies exploring new ways to treat several difficult-to-manage cancers and rare tumors. The research includes work on improving treatment effectiveness, delaying disease progression, and testing promising therapies for both early-stage and advanced disease.

• Endometrial cancer research is evaluating a new maintenance approach for advanced or recurrent disease to better control cancer growth.
• Studies in colorectal cancer are assessing short-course preoperative targeted treatments for molecularly selected resectable tumors.
• Trials in ovarian, fallopian tube, and primary peritoneal cancers are testing maintenance strategies for platinum-sensitive disease.
• Breast cancer research covers both ER-positive/HER2-negative early breast cancer and HER2-low or HER2 IHC 0 metastatic breast cancer, with studies aimed at improving anti-tumor activity and treatment outcomes.
• A rare tumor study is focused on tenosynovial giant cell tumor, evaluating whether a new therapy can reduce tumor activity.

Overall, the site’s oncology team is investigating therapies designed to improve response rates, extend progression-free survival, and support more effective care across a range of solid tumors.